drugset / Trial / NCT00563056
An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma
RandomizedParallel-groupOpen-labelTreatment
Summary
Flutiform® compared with the individual components Flixotide® (Fluticasone) and Foradil® (Formoterol) in adolescent and adult patients.
Timeline
- Start
- 2007-09
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluticasone | Other / unclassified | 100 ug | Inhaled |
| Comparator | Fluticasone | Other / unclassified | 250 ug | Inhaled |
| Comparator | Formoterol | Other / unclassified | 12 ug | Inhaled |
| Subject | fluticasone/formoterol | Unknown | — | Inhaled |